The Potent Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitor HR212 Blocks Formation of the Envelope Glycoprotein gp41 Six-Helix Bundle-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Potent Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitor HR212 Blocks Formation of the Envelope Glycoprotein gp41 Six-Helix Bundle

Published:2013-03 Issue:3 Volume:29 Page:613-620
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Ouyang Wenjie¹,An Tai¹,Guo Deyin¹,Wu Shuwen¹,Tien Po¹²

Affiliation:

1. State Key Laboratory of Virology and Modern Virology Research Center, The College of Life Sciences, Wuhan University, Wuhan, China.

2. The CAS Key Laboratory of Pathogenic Microbiology and Immunology, Center for Molecular Virology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2012.0059

Reference34 articles.

1. HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics

2. HIV-1 Membrane Fusion

3. Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor

4. The entry of entry inhibitors: A fusion of science and medicine

5. The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening HIV-1 fusion inhibitors based on capillary electrophoresis head-end microreactor targeting to the core structure of gp41;Journal of Pharmaceutical and Biomedical Analysis;2016-02

2. HIV-1 envelope glycoprotein structure;Current Opinion in Structural Biology;2013-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP